Literature DB >> 19500284

Brain natriuretic peptide levels in Kawasaki disease: a case report.

Satoru Iwashima1, Takamichi Ishikawa, Takehiko Ohzeki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19500284     DOI： 10.1111/j.1442-200X.2009.02832.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN： 1328-8067            Impact factor:   1.524


× No keyword cloud information.
  4 in total

1.  Cardiovascular biomarkers in acute Kawasaki disease.

Authors:  Yuichiro Z Sato; Delaram P Molkara; Lori B Daniels; Adriana H Tremoulet; Chisato Shimizu; John T Kanegaye; Brookie M Best; James V Snider; Jeffrey R Frazer; Alan Maisel; Jane C Burns
Journal:  Int J Cardiol       Date:  2011-07-20       Impact factor: 4.164

2.  Increased serum pro-B-type natriuretic peptide in hematopoietic progenitor cell donors stimulated with G-CSF.

Authors:  Leonard N Chen; Celina Montemayor-Garcia; Kamille A West-Mitchell; Cathy C Cantilena
Journal:  J Clin Apher       Date:  2022-03-18       Impact factor: 2.605

3.  B-type natriuretic peptide and N-terminal pro-BNP in the acute phase of Kawasaki disease.

Authors:  Satoru Iwashima; Takamichi Ishikawa
Journal:  World J Pediatr       Date:  2013-01-18       Impact factor: 2.764

4.  Log-transformed plasma level of brain natriuretic peptide during the acute phase of Kawasaki disease is quantitatively associated with myocardial dysfunction.

Authors:  Sunhee Bang; Jeong Jin Yu; Myung-Ki Han; Hong Ki Ko; Sail Chun; Hyung Soon Choi; Young-Hwue Kim; Jae-Kon Ko; In-Sook Park
Journal:  Korean J Pediatr       Date:  2011-08-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.